Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec versus insulin glargine for nocturnal hypoglycaemia risk in adults with type 1 diabetes
2014-001942-24Phase 4Completed
- Sponsor
- Nordsjællands Hospital
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin degludec and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Nordsjællands Hospital. Primary endpoint: Rate of symptomatic nocturnal hypoglycaemia confirmed by glucose measurement. Started Jul 2014; status: completed.
02
Drugs
insulin degludecinsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-001942-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001942-24.